First real-world data shows Oxford and Pfizer jabs cut TWO THIRDS of Covid cases and transmissions

The first ‘real-world’ data examining the impact of vaccines suggests the Oxford and Pfizer jabs cut two thirds of infections and transmissions.

The data, which supports Britain’s policy of widening the time between doses, will show one shot of either of the vaccines will have that effect on people of all ages.

Boris Johnson is expected to hear evidence on the impact of jabs on transmission, infection, hospital admissions and deaths by the end of Friday.

This will be ahead of the PM’s highly-anticipated ‘roadmap’ out of England’s lockdown on Monday.

It comes as it was revealed Britons as young as 40 could be offered a jab within a few weeks.

Government advisers are set to recommend the next phase of the vaccine rollout continues on the basis of age, rather than prioritising key workers.

The data, which supports Britain’s policy of widening the time between doses, will show one shot of either of the vaccines will have that effect on people of all ages. Pictured: A person gets the coronavirus vaccine in Westfield Stratford City shopping centre on Thursday

Boris Johnson is expected to hear evidence on the impact of jabs on transmission, infection, hospital admissions and deaths by Friday

Boris Johnson is expected to hear evidence on the impact of jabs on transmission, infection, hospital admissions and deaths by Friday

This will come ahead of the PM's highly-anticipated 'roadmap' out of England's lockdown on Monday

This will come ahead of the PM’s highly-anticipated ‘roadmap’ out of England’s lockdown on Monday

The ‘real world’ data, from Public Health England studies with 40,000 healthcare workers and 9,000 care homes, are to be released later this month.

But Mr Johnson is reportedly going to get preliminary results – showing the positive impact of the Oxford and Pfizer jabs in cutting infections – early.

Sources told the Telegraph the data was ‘very encouraging’ and will play a large part in when England is opened up again.

Most of the data is on the effect of the Pfizer/BioNTech vaccine after doses were first given in December.

But similar results were found with the Oxford/AstraZeneca jabs, just on a smaller scale due to it being rolled out later.

A PHE spokesman said: ‘We have been analysing the data since the start of the vaccination rollout and will publish our findings in due course.’

Meanwhile it was revealed today Britons as young as 40 could be offered a jab within a few weeks.

Government advisers are set to recommend the next phase of the vaccine rollout continues on the basis of age, rather than prioritising key workers.

But the age brackets will be wider than before – meaning 40 to 49-year-olds are likely to be invited to have a jab once the 32million people in the top nine groups have had their first dose.

Earlier this week it emerged this target could be hit as soon as March 24, if the daily average is maintained.

This would mean the over-40s being invited for a jab in less than five weeks.

It would be a huge boost for Britain’s vaccine programme and could add to the pressure on ministers to ease the lockdown sooner.

The priority list for the rollout is determined by the Government’s Joint Committee on Vaccination and Immunisation, which met yesterday to draft its recommendations for the next phase.

These are expected to be signed off by members today before being sent to ministers to approve at the start of next week.

It is understood the committee rejected the idea of prioritising key workers or ethnic minorities in favour of a simple age-based approach.

Vaccine age bands are set to be widened, with no priority for key workers, meaning that over-40s could get a first does of a Covid jab by the end of March. Pictured: A vaccinator administers an injection of AstraZeneca/Oxford Covid-19 vaccine to a patient at the vaccination centre set up at Chester Racecourse, in Chester, England, on February 15

Vaccine age bands are set to be widened, with no priority for key workers, meaning that over-40s could get a first does of a Covid jab by the end of March. Pictured: A vaccinator administers an injection of AstraZeneca/Oxford Covid-19 vaccine to a patient at the vaccination centre set up at Chester Racecourse, in Chester, England, on February 15

In further encouraging news Public Health England (PHE) said cases were still falling in all regions, while separate figures suggested deaths among the over-80s are down by two thirds in three weeks.

Boris Johnson is due to unveil his roadmap out of lockdown on Monday after a meeting of his ‘Covid O’ committee and data – expected today – on how well the vaccine rollout is working.

The Mail revealed this week that under the current plans, life is unlikely to return to normal until July.

That has led to pressure on Mr Johnson to go further in easing restrictions.

The first 15million people to receive the jab were prioritised by five-year age bands, and also included front-line health and social care workers.

The current phase includes everyone over 50 as well as those who have certain underlying medical conditions.

It had been thought this group would all have been offered the first dose by the start of May, but it emerged earlier this week that the target could be hit much sooner – potentially in late March.

A graph showing the number of vaccines per day in the UK. Over 16.4 million people have so far received at least one dose in the UK

A graph showing the number of vaccines per day in the UK. Over 16.4 million people have so far received at least one dose in the UK

The issue of who should be prioritised next has been debated for weeks, with many arguing key workers – such as police or teachers – should be offered a jab first.

It has also been suggested ethnic minorities should be prioritised as data from the first wave suggested they were up to twice as likely to die from Covid.

Members of the JCVI are said to be satisfied that those at highest risk within the key worker and ethnic minority groups are already accounted for, due to being ‘clinically vulnerable’ or ‘over 50’.

However, they are believed to have suggested the age brackets could be widened from five years to ten in the next phase.

This is because the difference in death risk between someone aged 30 and someone aged 39 is significantly less than between a 70-year-old and a 79-year-old.

There is therefore no need to segment younger people into such narrow age categories.

Ministers may still take a ‘political decision’ to prioritise teachers and other front-line workers, contrary to the committee’s guidance.

There is a chance some other medical conditions may be added to the priority list, too.

A source said: ‘Members are now close to an agreement on what the next stage of the vaccine rollout programme should look like.’